Save the Date: Revitas to Host Life Sciences Industry Summit in Philadelphia

Revitas's annual Industry Summit: Life Sciences will be held on November 5-6, 2013 at the Four Seasons Philadelphia. This industry event features a combination of thought leadership tracks, keynote speakers, and user best practice sessions designed to showcase the power of Enterprise Revenue Dynamics.

Capitalizing on the success of last year's Summit, the 2013 Revitas Industry Summit: Life Sciences event will bring together approximately 250 Revitas customers, partners, industry professionals, and executives to learn and share best practices, and network with colleagues and industry experts.

The event will focus on the complex issues facing life sciences companies in contracting, pricing, and compliance. Last year’s industry keynote presenter Adam J. Fein, Ph.D., Founder and President of Pembroke Consulting Inc. and author of the Drug Channels website, spoke about how government regulation, shifting market lines, and increased transparency have challenged the life sciences. The 2013 Summit will push that conversation forward, addressing how the industry is handling global revenue management issues, where it is heading in 2013 and beyond, and how life sciences organizations can better manage their commercial and government contracting strategies through Enterprise Revenue Dynamics.

“Over the past year, the life sciences industry has gained some clarity through the Supreme Court’s Affordable Care Act ruling, but this clarity is fraught with complex regulations and new challenges,” said Al Smith, President and COO of Revitas. “Back by popular demand, the Revitas Industry Summit: Life Sciences will be an epicenter of thought leadership on the current life sciences landscape. With a global client base of midsize and large-scale companies across multiple industries, we understand the challenges of channel distribution in international markets. We’re bringing together executives and operational leaders of the foremost pharmaceutical companies to share global revenue management trends, strategies for emerging growth companies, opportunities for generics manufacturers, and forecasting and accrual tactics that will help these companies strengthen their businesses to drive revenue growth while maintaining rock-solid compliance.”